Background illustration for clinical trials search

Paid Clinical Trials Dayton

Discover 1,171 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

for
Multiple Myeloma
Location: Cincinnati OH, Nashville TN, Roanoke VA, Fairfax VA,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05972135

Phase2, Recruiting

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

for
Metastatic HER2-positive Breast Cancer
Location: Cincinnati OH, Nashville TN, Roanoke VA, Milwaukee WI,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06435429

Phase3, Recruiting

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

for
Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors,
Location: Cincinnati OH, Nashville TN, Washington D.C. DC,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1 - 70+

Code: NCT05868629

Recruiting

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Cincinnati OH, Columbus OH, Louisville KY, Ann Arbor MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05552222

Phase3, Recruiting

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Cincinnati OH, Niles IL, Nashville TN, Peoria IL,
Sponsor: BioNTech SE

Sex: Male

Age: 18+

Code: NCT07365995

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Cincinnati OH, Lexington KY, Canton OH, Chicago IL,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06203210

Phase3, Recruiting

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Cincinnati OH, Louisville KY, Chicago IL, Nashville TN,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT07188558

Phase3, Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Cincinnati OH, Hilliard OH, Columbus OH, Fort Wayne IN,
Sponsor: Incyte Corporation

Sex: Female

Age: 18 - 70+

Code: NCT07023627

Phase2, Recruiting

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

for
T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Location: Cincinnati OH, Nashville TN, St Louis MO,
Sponsor: Allotera Therapeutics

Sex: All

Age: 0+

Code: NCT06514794

Phase2, Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Cincinnati OH, Louisville KY, Pittsburgh PA, Chicago IL,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06943872

Phase3, Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06095505

Phase2, Recruiting

MYLUNG Consortium Part 3: Observational Study

for
Carcinoma, Non-Small-Cell Lung
Location: Cincinnati OH, Chicago Ridge IL, Blacksburg VA,
Sponsor: US Oncology Research

Sex: All

Age: 18+

Code: NCT05885698

Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: Cincinnati OH, Fort Wayne IN, Akron OH,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Cincinnati OH, Columbus OH, Lexington KY, Cleveland OH,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06619561

Phase2, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase3, Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for
Relapsed or Refractory Multiple Myeloma
Location: Cincinnati OH, Cleveland OH, Ann Arbor MI,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT05519085

Phase3, Recruiting

Pan Tumor Rollover Study

for
Cancer
Location: Cincinnati OH, Columbus OH, Louisville KY, Nashville TN,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT03899155

Phase2, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase3, Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase2, Phase3, Recruiting

Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

for
Relapsed/Refractory Acute Myeloid Leukemia
Location: Cincinnati OH, Columbus OH, Grand Rapids MI, Chicago IL,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06714591

Phase1, Recruiting